Institutional financial conflicts of interest policies at Canadian academic health science centres: A national survey

Open Medicine

Volumn 4, Issue 3, 2010, Pages

  Rochon, Paula A ^a   Sekeres, Melanie ^a   Lexchin, Joel ^a   Moher, David ^b   Wu, Wei ^c   Kalkar, Sunila R ^c   Van Laethem, Marleen ^d   Hoey, John ^e   Chan, An Wen ^c   Gruneir, Andrdrea ^a   Gold, Jennifer ^f   Maskalyk, James ^d   Streiner, David L ^d   Taback, Nathan ^d   Ferrrris, Lorrrraine E ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

^f Legal counsel   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956054699     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research. Protecting patients, preserving integrity, advancing health: accelerating the implementation of COI policies in human subjects research. Washington (DC): Association of American Medical Colleges; 2008. Available: https://services.aamc.org/publications/index.cfm?fuseaction=Product.displayForm&prd_id=220.
2. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research. Washington (DC): Association of Americal Medical Colleges; 2002. Available: http://www.aamc.org/research/coi/2002coireport.pdf.
3. Barnes M, Florencio PS. Financial conflicts of interest in human subjects research: the problem of institutional conflicts. J Law Med Ethics 2002;30(3):390-402.
4. Rothman DJ. Academic medical centers and financial conflicts of interest. JAMA 2008; 299(6):695-697.
5. Rudy AP, Coppin D, Konefal J, Shaw BT, Ten Eyck T, Harris C, et al. Universities in the age of corporate science: The UC Berkeley- Novartis controversy. Philadelphia (PA): Temple University Press; 2007.
6. NIH in the spotlight over conflicts of interest. Lancet Neurol 2004;3(11):633.
7. National Institutes of Health. Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Policies. A Working Group of the Advisory Committee to the Director . Bethesda (MD): National Institutes of Health; 2004. Available: http://www.nih.gov/about/ethics_COI_panelreport.htm.
8. Brockway LM, Furcht LT; FASEB. Conflicts of interest in biomedical research-the FASEB guidelines. FASEB J 2006;20(14):2435-2438.
9. Kim SYH, Millard RW, Nisbet P, Cox C, Caine ED. Potential research participants' views regarding researcher and institutional financial conflicts of interest. J Med Ethics 2004;30(1):73-79.
10. AAU Task Force on Research Accountability. Report on individual and institutional financial conflict of interest. Washington (DC): Association of American Universities; 2001. Available: www.aau.edu/research/COI.01.pdf.
11. Ehringhaus S, Korn D. U.S. medical school policies on individual financial conflicts of interest: results of an AAMC survey. Washington (DC): American Association of Medical Colleges; 2004. Available: http://www.aamc.org/research/coi/coiresults2003.pdf.
12. Ferris LE, Naylor CD. Promoting tntegrity in industry-sponsored clinical drug trials: conflict of interest for Canadian academic health sciences centers. In: Lemmens T, Waring DR, editors. Law and ethics in biomedical research: regulation, conflict of interest, and liability. Toronto: University of Toronto Press; 2006. p 95-131.
13. Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993;329(8):573-576.
14. Morgenson G, Harvey CR. The New York Times dictionary of money and investing: the essential a to z guide to the language of the new market. New York: Times Books; 2002.
15. MacDonald C, McDonald M, Norman W. Charitable conflicts of interest. J Bus Ethics 2002;39(1-2):67-74.
16. Blumenthal D. Academic-industrial relationships in the life sciences. N Engl J Med 2003;349(25):2452-2459.
17. Global Development Research Centre. Notes on technology transfer. Available: www.gdrc.org/uem/techtran.html.
18. Ehringhaus SH, Weissman JS, Sears JL, Goold SD, Feibelmann S, Campbell EG. Responses of medical schools to institutional conflicts of interest. JAMA 2008;299(6):665-671.
19. Wasserstein AG, Brennan PJ, Rubenstein AH. Institutional leadership and faculty response: fostering professionalism at the University of Pennsylvania School of Medicine. Acad Med 2007;82(11):1049-1056.
20. Slaughter S, Feldman MP, Thomas SL. U.S. research universities' institutional conflict of interest policies. J Empir Res Hum Res Ethics 2009;4(3):3-20.
21. Natural Sciences and Engineering Research Council of Canada. Schedule 14: Conflicts of interest in research. Memorandum of understanding (MOU) on the roles and responsibilities in the management of federal grants and awards. Available: http://www.nserc.gc.ca/institution/mou_e.htm.
22. Lo B, Field MJ, editors. Conflict of interest in medical research, education, and practice. Washington (DC): National Academies Press; 2009. Available: http://www.nap.edu/catalog.php?record_id=12598#toc.